Drug
Formoterol
Formoterol: highest development phase Post-Market, developed by Chiesi Farmaceutici, Lupin. 2 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Chiesi Farmaceutici, Lupin
Trials
| Drug | Phase | Indication |
|---|---|---|
| Formoterol NCT01892787 | Post-Market | Asthma |
| FORMOTEROL FUMARATE | Approved |
Latest
No recent events.
Follow Formoterol on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.